This October, Curaleaf Holdings, Inc. (TSX: CURA OTCQX: CURLF) is marking the sixth anniversary of its national donation program for Breast Cancer Action Month, reaffirming its commitment to driving impactful change outside the usual playbooks of corporate giving. Rather than limiting support to a press release, Curaleaf is partnering with The Baldwin Fund, officially The Carol M. Baldwin Breast Cancer Research Fund of CNY, to give everyday customers a real say in cancer research funding and patient care advancements.
For anyone unfamiliar, The Baldwin Fund was founded by Carol M. Baldwin, a woman whose determined family and motto, “Together We Will Find a Cure,” have helped raise over $13 million for breast cancer research over the last 20 years. This year, the Fund is taking on a much larger goal: securing $50 million to help Upstate Cancer Center in Syracuse reach National Cancer Institute designation, a recognition that can transform a regional cancer program into a hub for breakthrough science and patient care.
During October, the round-up-at-register program is a way for Curaleaf customers to make a small but very tangible difference. Visit one of Curaleaf’s retail stores in Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, or Utah, and you can choose to round up your purchase at the counter, with 100% of those proceeds going directly to supporting The Baldwin Fund’s work at Upstate Medical University. Curaleaf emphasizes that this goes far past honoring the stories of survivors; it means fueling real research into treatments and offering direct support to families who are navigating the realities of breast cancer.
Stephen Baldwin, representing The Baldwin Fund, brings a personal perspective to the partnership. He puts Curaleaf front and center, not simply as another corporate partner but as a trusted brand that he’s supported since the day their doors opened. When asked about the collaboration, Baldwin shared, “This partnership with Curaleaf not only carries my mother’s legacy forward but also gives people across the country an easy and meaningful way to join us in the fight against breast cancer. I truly believe it’s the most trustworthy brand and product in the industry, with a deep commitment to quality and community. By rounding up at the register, every customer can play a role in honoring survivors, supporting families, and funding the research that will one day end this disease.”
Boris Jordan, Curaleaf’s chairman and CEO, notes that Breast Cancer Action Month is more than just a moment for Curaleaf, it’s a chance to connect with communities and recognize those affected by breast cancer, whether they’re living with it today or remembering loved ones who have passed. While Curaleaf does not claim that cannabis products treat cancer, the company is mindful that many patients use cannabis to help manage discomfort linked to cancer treatments, such as pain, nausea, anxiety, or insomnia. Curaleaf remains committed to providing high-quality, safe cannabis for patients and consumers while advocating for more robust research on how the plant interacts with cancer care.
State regulations mean not every Curaleaf dispensary can join the donation effort, but most will participate, leveraging the company’s broad retail footprint in 13 states. This program is simple: round up, donate, and know you’re part of a real change. The proceeds support teams at Upstate Medical University, powering a push for NCI status that could benefit cancer patients across New York and beyond.
Both Curaleaf and The Baldwin Fund highlight that community involvement in research funding can accelerate the path to a cure. Customers are encouraged to take the opportunity this October to round up at the register and be part of a movement that has raised millions for science and patient care. It’s proof that collective action, even in small amounts, can build a better future for those affected by breast cancer and push critical research that may change lives.
